Legislative Priorities & Position Statements

The Second Session of the 110th Congress Goals and Issue Briefs - The Leukemia & Lymphoma Society actively supports public policy initiatives that will improve the lives of those with cancer

Clinical Trials Access - The Leukemia & Lymphoma Society's volunteers and staff, as well as patients and their families, actively support public policy initiatives that will improve the lives of those with a blood cancer

Statement on Federal and State Tax Policy - The Leukemia & Lymphoma Society promotes federal and state tax policies that enhance the financial incentives of making charitable contributions and increase access to charitable institutions

Statement on Medical Records Privacy - Of particular concern to the Society is the development of standards for the use of confidential medical information in biomedical research

Legislative Testimony - Read the testimony of George Dahlman at a May 15, 2003 U.S. Senate hearing

Medicare Reimbursement for Oncology Treatments: Threat and Response - A continuing issue facing the cancer community and threatening the availability and quality of cancer care involves the Medicare reimbursement for physicians providing chemotherapy and treatment in their offices and in hospital outpatient facilities

Coalition Letters - This page contains coalition letters that LLS has signed onto

House Testimony - Read George Dahlman's statement in support of strenghthened congressional funding for cancer research

back to top